Catheter Precision Inc. (VTAK)
AMEX: VTAK
· Real-Time Price · USD
0.42
-0.18 (-30.01%)
At close: Jun 12, 2025, 3:59 PM
Catheter Precision Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 212K | 143K | 149K | 96K | 93K | 82K | 128K | 133K | 96K | 85K | 14K | n/a | 5K | 9K | 5K | 5K | 1M | 1.12M |
Cost of Revenue | 14K | 11K | 11K | 10K | 16K | 5K | 7K | 6K | 7K | 10K | 161K | 74K | 66K | 95K | 347K | 246K | 1.49M | 1.37M |
Gross Profit | 198K | 132K | 138K | 86K | 77K | 77K | 121K | 127K | 89K | 75K | -147K | -74K | -61K | -86K | -342K | -241K | -483K | -255K |
Operating Income | -4.69M | -3.56M | -3.05M | -2.86M | -2.72M | -2.62M | -2.6M | -2.73M | -6.31M | -66.48M | -8.21M | -4.78M | -8.46M | -5.5M | -8.26M | -7.39M | -7.24M | -7.18M |
Interest Income | 3K | 18K | 34K | 7K | 2K | 30K | 72K | 87K | 119K | 69K | n/a | 24K | n/a | n/a | n/a | n/a | 1K | 1K |
Pretax Income | -6.41M | -4.77M | -2.49M | -4.12M | -4.22M | -2.67M | -669K | -1.93M | -1.58M | -66.4M | -8.16M | -4.76M | -8.45M | -5.5M | -8.28M | -7.38M | -5.25M | -7.24M |
Net Income | -5.46M | -4.04M | -5.63M | -4.12M | -4.22M | -2.67M | -669K | -1.93M | -1.58M | -66.4M | -8.16M | -4.76M | -8.45M | -5.5M | -8.29M | -4.3M | -5.25M | -7.24M |
Selling & General & Admin | 2.88M | 3.48M | 3.1M | 2.88M | 2.71M | 2.66M | 2.73M | 2.75M | 1.42M | 10.23M | 7.96M | 3.51M | 2.48M | 2.3M | 4.19M | 4.21M | 3.74M | 4.11M |
Research & Development | 2M | 103K | 91K | 63K | 81K | 37K | -11K | 112K | 134K | 240K | 154K | 727K | 2.4M | 3.12M | 3.73M | 2.94M | 3.02M | 2.82M |
Other Expenses | n/a | 108K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 59K | 20K | 12K | 8K | -19K | 16K | n/a | n/a |
Operating Expenses | 4.88M | 3.7M | 3.19M | 2.94M | 2.79M | 2.69M | 2.72M | 2.86M | 1.55M | 10.47M | 8.11M | 4.24M | 4.87M | 5.42M | 7.92M | 7.15M | 6.76M | 6.93M |
Interest Expense | 67K | -49K | 51K | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K | 52K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.9M | 3.71M | 3.2M | 2.96M | 2.81M | 2.7M | 2.73M | 2.86M | 1.56M | 10.48M | 8.11M | 4.24M | 4.94M | 5.51M | 8.27M | 7.4M | 8.25M | 8.3M |
Income Tax Expense | -950K | -724K | 3.14M | n/a | n/a | n/a | n/a | n/a | 5.13M | 56.02M | 3K | 542K | 3.53M | n/a | 4K | n/a | 31K | 1K |
Shares Outstanding (Basic) | 13.34M | 11.28M | 8M | 2.05M | 757.34K | 7.43M | 7.03M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134.84K | 128K | 81.78K | 58.34K |
Shares Outstanding (Diluted) | 13.34M | 11.28M | 8M | 2.05M | 757.34K | 7.43M | 7.03M | 6.81M | 5.36M | 2.73M | 2.16M | 1.09M | 643.24K | 400.75K | 134.84K | 128K | 81.78K | 58.34K |
EPS (Basic) | -0.38 | -0.36 | -1.35 | -2.01 | -5.57 | -0.36 | -0.1 | -0.28 | -0.29 | -24.35 | -3.78 | -4.36 | -13.13 | -13.71 | -61.46 | -33.58 | -64.18 | -124.03 |
EPS (Diluted) | -0.38 | -0.36 | -1.35 | -2.01 | -5.57 | -0.36 | -0.1 | -0.28 | -0.29 | -24.35 | -3.78 | -4.36 | -13.13 | -13.71 | -61.46 | -33.58 | -64.18 | -124.03 |
EBITDA | -5.81M | -3.56M | -1.91M | -3.57M | -2.19M | -2.09M | -2.08M | -2.21M | -1.58M | -8.95M | -8.13M | -4.17M | -4.8M | -5.21M | -7.88M | -7.08M | -6.31M | -6.42M |
EBIT | -6.34M | -4.72M | -2.44M | -4.09M | -2.72M | -2.62M | -2.6M | -2.73M | -1.46M | -10.4M | -8.16M | -4.24M | -4.93M | -5.5M | -8.26M | -7.39M | -6.74M | -6.87M |
Depreciation & Amortization | 529K | 531K | 531K | 519K | 515K | 522K | 517K | 520K | -406K | 1.44M | 25K | 74K | 236K | 286K | 400K | 300K | 426K | 455K |